Duquesne Family Office LLC / PTGX
Duquesne Family Office LLC’s Protagonist Therapeutics Inc Position
Does Duquesne Family Office LLC own Protagonist Therapeutics Inc (PTGX)? Yes — 159.7K shares worth $17M (+0.50% of its 13F portfolio) as of Q1 2026.
Position Value
$17M
Q1 2026
Shares
159.7K
% of Portfolio
+0.50%
Quarters Held
3
currently held
Position History PTGX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of PTGX.